文献速递泌尿生殖腹部MR

膀胱影像报告和数据系统(VI-RADS)检测肌层浸润性膀胱癌的诊断准确性:一项Meta分析

Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis.
PubMed 文献 · Abdom Radiol (NY) · 2022-02-18

该Meta分析纳入19项研究共2900例患者,评估VI-RADS评分3和4预测膀胱癌肌层浸润的诊断效能。VI-RADS 3的合并敏感度和特异度分别为0.92(95%CI 0.89-0.94)和0.82(95%CI 0.76-0.87);VI-RADS 4分别为0.78(95%CI 0.72-0.83)和0.96(95%CI 0.93-0.97);两者AUC均为0.94(95%CI 0.92-0.96)。VI-RADS 3和4作为截断值提供相似的总体诊断效能,可分别选择性应用。

要点

  • VI-RADS 3预测肌层浸润的合并敏感度为0.92(95%CI 0.89-0.94),特异度为0.82(95%CI 0.76-0.87)。
  • VI-RADS 4预测肌层浸润的合并敏感度为0.78(95%CI 0.72-0.83),特异度为0.96(95%CI 0.93-0.97)。
  • VI-RADS 3与4的AUC均为0.94(95%CI 0.92-0.96),两者作为截断值提供相似的总体诊断效能。

核心结论

  • VI-RADS对预测膀胱癌肌层浸润显示出良好的诊断性能,并具有较好的临床实用性和适用性。
  • VI-RADS 3和4作为截断值提供相似的总体诊断效能,可分别选择性应用。
  • 需要大规模前瞻性研究进一步验证VI-RADS评分的准确性。

研究设计与样本

  • 研究类型为Meta分析,系统检索Cochrane Library、Embase和PubMed从建库至2021年10月。
  • 最终纳入19项研究,共2900例患者。
  • 评估对象为VI-RADS评分3和4对膀胱癌肌层浸润的预测效能,VI-RADS基于多参数MRI(mp-MRI)的五分评分法。

诊断标准与关键数值

  • VI-RADS 3预测肌层浸润的合并敏感度为0.92(95%CI 0.89-0.94),合并特异度为0.82(95%CI 0.76-0.87)。
  • VI-RADS 4预测肌层浸润的合并敏感度为0.78(95%CI 0.72-0.83),合并特异度为0.96(95%CI 0.93-0.97)。
  • VI-RADS 3和4的AUC均为0.94(95%CI 0.92-0.96)。
  • VI-RADS 3的发表偏倚检验P=0.74,VI-RADS 4的发表偏倚检验P=0.57,未观察到显著发表偏倚。

临床应用与阅片要点

  • VI-RADS 3和4作为截断值提供相似的总体诊断效能,可分别选择性应用。
  • VI-RADS对预测膀胱癌肌层浸润显示出良好的诊断性能,具有较好的临床实用性和适用性。

局限性

  • 需要大规模前瞻性研究进一步验证VI-RADS评分的准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Vesical Imaging-Reporting and Data System (VI-RADS) was proposed and considered as a standardized reporting criterion for bladder magnetic resonance imaging (MRI). VI-RADS could suggest the likelihood of muscle invasion based on the multiparametric MRI (mp-MRI) findings which contain five-point scores. The current study is designed to comprehensively and systematically evaluate the diagnostic performance of VI-RADS (score 3 and 4) for predicting muscle invasion.

METHODS: The Cochrane Library, Embase, and PubMed were searched comprehensively from inception to October 2021.

RESULTS: Finally, 19 studies incorporating 2900 patients were enrolled. The pooled sensitivity and specificity of VI-RADS 3 for predicting muscle invasion were 0.92 (95%CI 0.89-0.94) and 0.82 (95%CI 0.76-0.87), respectively. The pooled sensitivity and specificity of VI-RADS 4 were 0.78 (95%CI 0.72-0.83) and 0.96 (95%CI 0.93-0.97), respectively. And the area under the curve (AUCs) of VI-RADS 3 and 4 were all 0.94 (95%CI 0.92-0.96). No significant publication biases were not observed for VI-RADS 3 (P = 0.74) and 4 (P = 0.57).

CONCLUSION: The VI-RADS reveals a good diagnostic performance for predicting muscle invasive in bladder cancer, which also has good clinical utilities and applicability. And VI-RADS 3 and 4 as cutoff values provide similar overall diagnostic and could be selectively applied individually. Prospective studies with a large scale are further required to validate the accuracy of the VI-RADS score.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Feng, Zhong, Chen, et al. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis. Abdom Radiol (NY). 2022. PMID: 35181798. doi:10.1007/s00261-022-03449-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。